FWWMX
Price
$66.89
Change
-$0.95 (-1.40%)
Updated
Nov 13 closing price
Net Assets
209.34B
JHJAX
Price
$24.75
Change
-$0.34 (-1.36%)
Updated
Nov 13 closing price
Net Assets
122.06M
Interact to see
Advertisement

FWWMX vs JHJAX

Header iconFWWMX vs JHJAX Comparison
Open Charts FWWMX vs JHJAXBanner chart's image
American Funds Washington Mutual 529-F-3
Price$66.89
Change-$0.95 (-1.40%)
VolumeN/A
Net Assets209.34B
JHancock ESG Large Cap Core A
Price$24.75
Change-$0.34 (-1.36%)
VolumeN/A
Net Assets122.06M
FWWMX vs JHJAX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FWWMX has more cash in the bank: 209B vs. JHJAX (122M). FWWMX pays higher dividends than JHJAX: FWWMX (1.41) vs JHJAX (0.06). FWWMX was incepted earlier than JHJAX: FWWMX (5 years) vs JHJAX (9 years). JHJAX (1.33) is less costly to investors than FWWMX (0.31). JHJAX (30.00) and FWWMX (29.00) have comparable annual turnover. FWWMX has a lower initial minimum investment than JHJAX: FWWMX (250) vs JHJAX (1000). FWWMX annual gain was more profitable for investors over the last year : 3.95 vs. JHJAX (-3.85). FWWMX return over 5 years is better than : 49.35 vs. JHJAX (45.88).
FWWMXJHJAXFWWMX / JHJAX
Total Expense Ratio0.311.1228%
Annual Report Gross Expense Ratio0.311.3323%
Fund Existence5 years9 years-
Gain YTD9.9199.079109%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets209B122M171,311%
Annual Yield % from dividends1.410.062,226%
Returns for 1 year3.95-3.85-103%
Returns for 3 years32.8837.4288%
Returns for 5 years49.3545.88108%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWOAX19.23N/A
N/A
Fidelity Advisor Women's Leadership A
RAPIX11.46-0.08
-0.69%
Cohen & Steers Real Assets I
RTNAX14.33-0.11
-0.76%
Russell Inv Tax-Managed Intl Eq A
PWEAX17.48-0.14
-0.79%
PACE International Em Mkts Eq A
PHPIX29.71-0.63
-2.08%
ProFunds Pharmaceuticals UltraSector Inv